Molecular aspects of intracellular sterol esterification: The acyl coenzyme A:cholesterol acyltransferase reaction

Current Opinion in Lipidology

Volumn 8, Issue 3, 1997, Pages 167-173

  Sturley, Stephen L ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; CHOLESTEROL ACYLTRANSFERASE; COMPLEMENTARY DNA; STEROL;

AMINO ACID SEQUENCE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MEMBRANE; ENZYME REGULATION; ESTERIFICATION; GENE SEQUENCE; HOMEOSTASIS; HUMAN; LIPID METABOLISM; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; ESTERS; HOMEOSTASIS; HUMANS; MICE; MICE, MUTANT STRAINS; MULTIGENE FAMILY; PHYLOGENY; SACCHAROMYCES CEREVISIAE; STEROL O-ACYLTRANSFERASE; STEROLS;

EUKARYOTA;

EID: 0030859046     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199706000-00007     Document Type: Review

References (58)

1. Chang CCY, Huh HY, Cadigan KM, Chang TY: Molecular cloning and functional expression of human acyl coenzyme A: cholesterol acyl-transferase cDNA in mutant Chinese hamster ovary cells. J Biol Chem 1993, 268:20747-20755.
2. Liscum L, Underwood KW: Intracellular cholesterol transport and compartmentation. J Biol Chem 1995, 270:15443-15446.
3. Chang TY, Chang CCY, Cadigan KM: The structure of acyl-CoA cholesterol acyl transferase and its potential relevance to atherosclerosis. Trends Cadiovasc Med 1994, 4:223-230.
4. Tabas I: The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages. Curr Opin Lipidol 1995, 6:260-268. A comprehensive review of the mechanisms and consequences of regulation of sterol esterification by lipoproteins.
5. Libby P, Clinton SK: The role of macrophages in atherogenesis. Curr Opin Lipidol 1993, 4:3355-3363.
6. Hajjar DP: Regulation of cholesteryl ester hydrolases. Adv Enzymol Relat Areas of Mol Biol 1994, 69:45-82.
7. Chang T-Y, Doolittle GM: Acyl coenzyme A: cholesterol O-acyltransferase. In The enzymes, vol XVI. Edited by Boyer P. New York: Academic Press; 1983:523-539.
8. Warner GJ, Stoudt G, Bamberger M, Johnston WJ, Rothblatt GH: Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem 1995, 270:5772-5778.
9. Chang TY, Hasan MT, Chin J, Chang CCY, Spillane DM, Chen J: Chinese hamster ovary cell mutants affecting cholesterol metabolism. Curr Opin Lipidol 1997, 8:65-71. An exhaustive review of CHO cell mutants and their use in understanding sterol esterification and homeostasis.
10. Cheng D, Chang CC, Qu X, Chang TY: Activation of acyl-coenzyme A: cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J Biol Chem 1995, 270:685-695. High level expression of the hACAT cDNA in insect cells, followed by partial protein purification and liposome-mediated resolubilization, demonstrates the kinetic and regulatory profiles of the human enzyme. In addition, cholesterol and oxysterol are demonstrated to be allosteric effectors of ACAT regulation.
11. Chang CC, Chen J, Thomas MA, Cheng D, Del Priore VA, Newton RS, Pape ME, Chang TY: Regulation and immune-localization of acyl-coenzyme A: cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J Biol Chem 1995, 270:29532-29540. The authors identified posttranslational mechanisms as the mapr regulatory control of the ACAT reaction in fibroblasts and liver cell culture models. In addition, this study described immunolocalization of the ACAT protein to the endoplasmic reticulum.
12. Cao G, Goldstein JL, Brown MS: Complementation of mutation in acyl-CoA: cholesterol acyltransferase (ACAT) fails to restore sterol regulation in ACAT-defective sterol-resistant hamster cells. J Biol Chem 1996, 271:14642-14648. This study described the identification of the first mis-sense mutation (Ser to Leu at residue 265) in an ACAT gene that both nullifies sterol esterification and also renders the protein unstable.
13. Uelman PJ, Oka K, Sullivan M, Chang CCY, Chang TY, Chan L: Tissue-specific expression and cholesterol regulation of acylcoenzyme A : cholesterol acyltransferase (ACAT) in mice. Molecular cloning of mouse ACAT cDNA, chromosomal localization, and regulation of ACAT in vivo and in vitro. J Biol Chem 1995, 270:26192-26201. This work described the isolation of the mouse homolog of the human ACAT gene and confirmed its role in sterol esterification by complementation of CHO ACAT mutant cells.
14. Pape ME, Schultz PA, Rea TJ, DeMattos RB, Kieft K, Bisgaier CL, Newton RS, Krause BR: Tissue specific changes in acyl-CoA: cholesterol acyltransferase (ACAT) mRNA levels in rabbits. J Lipid Res 1995, 36:823-838.
15. Tabas I, Zha X, Maxfield F, Chang T-Y, Beatini N, Farese RV, Meiner V: Immunolocalization of acyl-CoA: cholesterol acyltransferase in mouse peritoneal macrophages: identification of peripheral sites that do not overlap with the endoplasmic reticulum marker, protein dilsulfide isomerase. Circulation 1996, 94:1-35.
16. Rumsey SC, Galeano NF, Lipschitz B, Deckelbaum RJ: Oleate and other long chain fatty acids stimulate low density lipoprotein receptor activity by enhancing acyl coenzyme A: cholesterol acyltransferase activity and altering intracellular regulatory cholesterol pools in cultured cells. J Biol Chem 1995, 270:10008-10016. Most studies identify cholesterol as the major regulator of the ACAT reaction. This work presents a role tor fatty acids in ACAT activity and sterol homeostasis.
17. Wang H, Germain SJ, Benfield PP, Gillies PJ: Gene expression of acyl-coenzyme-A: cholesterol-acyltransferase is upregulated in human monocytes during differentiation and foam cell formation. Arterioscler Thromb Vasc Biol 1996, 16:809-814.
18. Rea TJ, DeMattos RB, Homan R, Newton RS, Pape ME: Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells. Biochim Biophys Acta 1996, 1299:67-74.
19. Pentchev PG, Brady RO, Blanchette-Mackie EJ, Vanier MT, Carstea ED, Parker CC, Goldin E, Roft CF: The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol. Biochim Biophys Acta 1994, 1225:235-243. A review of the Niemann Pick C lesion; a defect in sterol esterification due to defective transport of sterol to the ACAT enzyme.
20. Debry P, Nash EA, Neklason DW, Metherall JE: Role of multidrug resistance P-glycoproteins in cholesterol esterification. J Biol Chem 1997, 272:1026-1031.
21. Brown MS, Dana SE, Goldstein JL: Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols. J Biol Chem 1975, 250:4025-4027.
22. Botham KM: Cyclic AMP and the regulation of cholesterol metabolism. Biochem Soc Trans 1992, 20:454-459.
23. Chang CC, Chang TY: Cycloheximide sensitivity in regulation of acyl coenzyme A : cholesterol acyltransferase activity in Chinese hamster ovary cells. 2. Effect of sterol endogenously synthesized. Biochemistry 1986, 25:1700-1706.
24. Chang CC, Doolittle GM, Chang TY: Cycloheximide sensitivity in regulation of acyl coenzyme A: cholesterol acyltransferase activity in Chinese hamster ovary cells. 1. Effect of exogenous sterols. Biochemistry 1986, 25:1693-1699.
25. Skiba PJ, Zha X, Maxfield F, Schissel S, Tabas I: The distal pathway of lipoprotein-induced cholesterol esterification, but not Spingo-myelinase-induced cholesterol esterification is energy-dependent. J Biol Chem 1996, 271:13392-13400.
26. Schissel SL, Beatini N, Zha X, Maxfield FR, Tabas I: Effect and cellular site of action of cysteine protease inhibitors on the cholesterol esterification pathway in macrophages and Chinese hamster ovary cells. Biochemistry 1995, 34:10463-10473.
27. Yang H, Bard M, Bruner DA, Gleeson A, Deckelbaum RJ, Aljinovic G, Pohl T, Rothstein R, Sturley SL: Sterol esterification in yeast: a two gene process. Science 1996, 272:1353-1356. The authors identified a gene family in this model eukaryote that is responsible for sterol esterification. Deletion of both genes nullifies sterol esterification and down-regulates sterol biosynthesis. The concept of multiple gene families for ACAT in all organisms is proposed based on the isolation of novel ACAT homologs from the database of expressed sequence tags.
28. Yu C, Kennedy NJ, Chang CCY, Rothblatt JA: Molecular cloning and characterization of two isoforms of Saccharomyces cerevisiae acylCoA: sterol acyltransferase. J Biol Chem 1996, 271:24157-24163.
29. Yang H, Cromley D, Wang H, Billheimer JT, Sturley SL: Functional expression of a cDNA to human acyl-CoA: cholesterol acyltransferase (ACAT) in yeast; species-dependent substrate specificity and inhibitor sensitivity. J Biol Chem 1997, 272. Functional complementation of a yeast strain lacking sterol esterification activity with the hACAT cDNA is presented. The sterol and acyl-CoA substrate preferences of the yeast and human reactions are compared.
30. Arthington-Skaggs BA, Crowell DN, Yang H, Sturley SL, Bard M: Positive and negative regulation of a sterol biosynthetic gene (ERG3) in the postsqualene portion of the yeast ergosterol pathway. FEBS Lett 1996, 392:161-165.
31. Goodman DS, Deykin D, Shiratori T: The formation of cholesterol esters with rat liver enzymes. J Biol Chem 1964, 239:1335-1344.
32. Meiner VM, Cases S, Myers H, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, Farese RV: Disruption of the acylCoA: cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A 1996, 93:14041-14046. The authors present the first mutant animal model for the ACAT reaction and illustrate the effect of loss of activity on intracellular sterol accumulation and serum cholesterol levels. Importantly, a tissue-specific profile of activity is demonstrated in the knockout animal, clearly affirming the concept of multiple genes for the process.
33. Welch CL, Xia Y-R, Shechter I, Farese R, Mehrabian M, Mehdizadeh S, Warden CH, Lusis AJ: Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. J Lipid Res 1996, 37:1406-1421.
34. Arnesen K: The cytology of the adrenal cortex in mice with spontaneous adrenocortical lipid depletion. Acta Pathol Microbiol Scand1963, 58:212-218.
35. Taylor BA, Meier H, Whitten WK: Chromosomal location and site of action of the adrenal lipid depletion gene of the mouse [Abstract]. Genetics 1974, 7:S65.
36. Chang CC, Noll WW, Nutile-McMenemy N, Lindsay EA, Baldini A, Chang W, Chang TY: Localization of acyl coenzyme A: cholesterol acyltransferase gene to human chromosome 1q25. Somatic Cell Mol Genet 1994, 20:71-74.
37. Becker A, Böttcher A, Lackner KJ, Fehringer P, Notka F, Aslanidis C, Schmitz G: Purification, cloning and expression of a human enzyme with acyl coenzyme A: cholesterol acyl transferase activity, which is identical to liver carboxyesterase. Arterioscler Thromb 1994, 14:1346-1355.
38. Diczfalusy MA, Bjorkhem I, Einarsson K, Alexson SE: Acyl-coenzyme A : cholesterol O-acyltransferase is not identical to liver microsomal carboxylesterase. Arterioscler Thromb Vasc Biol 1996, 16:606-610.
39. Thompson GR, Naoumova RP, Watts GF: Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res 1996, 37:439-447.
40. Corton JM, Hardie DG: Evidence against a role for phosphorylation/dephosphorylation in the regulation of acyl-CoA: cholesterol acyl transferase. Eur J Biochem 1992, 204:203-208.
41. Erickson SK, Lear SR, McCreery MJ: Functional sizes of hepatic enzymes of cholesteryl ester metabolism determined by radiation inactivation. J Lipid Res 1994, 35:763-769.
42. Guo Z, Yang H, Sturley SL: Multimerization of the human ACAT enzyme and mutagenesis of the genes required for sterol esterification in yeast. Circulation 1996, 94:1-35.
43. Davignon J: Prospects for drug therapy for hyperlipoproteinaemia. Diabete Metab 1995, 21:139-146.
44. Kusunoki J, Aragane K, Kitamine T, Higashinakagawa S, Kase N, Yamaura T, Ohnishi H: Hypocholesterolemic action and prevention of cholesterol absorption via the gut by F-1394, a potent acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, in cholesterol diet-fed rats. Jpn J Pharmacol 1995, 69:53-60.
45. Murakami S, Nara Y, Yamori Y: Hypolipidemic and antiatherosclerotic effects of a novel ACAT inhibitor, HL-004, in stroke-prone spontaneously hypertensive rats. Exp Mol Pathol 1995, 63:23-32. A profile of hypolipidemia and reduced tissue deposition of cholesterol is demonstrated in a rat model of hypertension and diet-induced hypercholesterolemia, due to the action of an ACAT inhibitor.
46. Krause BR, Pape ME, Kieft K, Auerbach B, Bisgaier CL, Homan R, Newton RS: ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance. Arterioscler Thromb 1994, 14:598-604.
47. Matsuo M, Ito F, Konto A, Aketa M, Tomoi M, Shimomura K: Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterolfed and WHHL rabbits. Evidence for a direct effect on the arterial wall. Biochim Biophys Acta 1995, 1259:254-260.
48. Nagata Y, Yonemoto M, Iwasawa Y, Shimizu-Nagumo A, Hattori H, Sawazaki Y, Kamei T: N-[2-[N′-pentyl-(6,6-dimethyl-2,4-heptadiynyl) amino]ethyl]-(2-methyl-1-naphthylthio)acetamide (FY-087). A new acyl coenzyme A: cholesterol acyltransferase (ACAT) inhibitor of diet-induced atherosclerosis formation in mice. Biochem Pharmacol 1995, 49:643-651.
49. Bocan TM, Mueller SB, Uhlendorf PD, Brown EQ, Mazur MJ, Black AE: Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig. Atherosclerosis 1993, 99:175-186.
50. Hainer JW, Terry JG, Connell JM, Zyruk H, Jenkins RM, Shand DL, Gillies PJ, Livak KJ, Hunt TL, Grouse JRr: Effect of the acyl-CoA : cholesterol acyltransferase inhibitor DuP 128 on cholesterol absorption and serum cholesterol in humans. Clin Pharmacol Ther 1994, 56:65-74.
51. O'Brien PM, Sliskovic DR, Picard JA, Lee HT, Purchase CFn, Roth BD, White AD, Anderson M, Mueller SB, Bocan T et al.: Inhibitors of acylCoA: cholesterol O-acyltransferase, synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5-acetamide and structurally related tetrazole amide derivatives. J Med Chem 1996, 39:2354-2366.
52. Dominick MA, McGuire EJ, Reindel JF, Bobrowski WF, Bocan TM, Gough AW: Subacute toxicity of a novel inhibitor of acyl-CoA: cholesterol acyltransferase in beagle dogs. Fundam Appl Toxicol 1993, 20:217-224.
53. Reindel JF, Dominick MA, Bocan TM, Gough AW, McGuire EJ: Toxicologie effects of a novel acyl-CoA: cholesterol acyltransferase inhibitor in cynomolgus monkeys. Toxicol Pathol 1994, 22:510-518.
54. Maduskuie T, Billheimer J, Germain S, Gillies P, Higley C, Johnson A, Pennev P, Shimshick E, Wexler R: Design, synthesis and structure-activity relationship studies for a new Imidazole series of J774 macrophage specific acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors. J Med Chem 1995, 38:1067-1083.
55. Plump AS, Smith JD, Hayek T, Aalto SK, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
56. Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
57. Rogler G, Trumbach B, Klima B, Lackner KJ, Schmitz G: HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol 1995, 15:683-690.
58. Francis GA, Knopp RH, Oram JF: Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest 1995, 96:78-87.